|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM357123093 |
003 |
DE-627 |
005 |
20231226071918.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2023.109649
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1190.xml
|
035 |
|
|
|a (DE-627)NLM357123093
|
035 |
|
|
|a (NLM)37209805
|
035 |
|
|
|a (PII)S1521-6616(23)00148-1
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Inaba, Masako
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Antigen-specific T cell balance reveals Why patients with atopic dermatitis fail to achieve immune tolerance
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 15.06.2023
|
500 |
|
|
|a Date Revised 21.06.2023
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2023 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a The number of regulatory T cells (Tregs) and how they behave in the pathogenesis of atopic dermatitis (AD) are still controversial. We identified and quantified Tregs, mite-specific Tregs, and mite-specific effector T cells (Teffs) in patients with AD and healthy controls (HCs). We collected peripheral blood and analyzed the cells using flow cytometry after stimulation with mite antigens. Mite-specific Tregs and mite-specific Teffs were recognized by the expression of CD137 and CD154, respectively. Patients with AD had more Tregs than HCs; however, when focusing on a single antigen, the ratio of mite-specific Tregs/Teffs was lower in patients with AD than in HCs. Furthermore, the mite-specific Teffs in patients with AD were more likely to produce proinflammatory cytokines interleukin (IL)-4 and IL-13. This Teff-dominant imbalance is thought to be the cause of development of atopic status in patients with AD without immune tolerance
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Antigen specificity
|
650 |
|
4 |
|a Atopic dermatitis
|
650 |
|
4 |
|a CD137
|
650 |
|
4 |
|a CD154
|
650 |
|
4 |
|a Mite antigen
|
650 |
|
4 |
|a Regulatory T cell
|
650 |
|
7 |
|a Antigens
|2 NLM
|
650 |
|
7 |
|a Cytokines
|2 NLM
|
700 |
1 |
|
|a Fukushima, Hiroko
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hara, Monami
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hosaka, Sho
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Fujiyama, Satoshi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Maruo, Kazushi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Nomura, Toshifumi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Okiyama, Naoko
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Takada, Hidetoshi
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 252(2023) vom: 25. Juli, Seite 109649
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:252
|g year:2023
|g day:25
|g month:07
|g pages:109649
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2023.109649
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 252
|j 2023
|b 25
|c 07
|h 109649
|